ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026
Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery.
Abstract read
In one paragraph
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain Cancer: Molecular Alterations and Emerging Trends in Neuropharmacology.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Andrew B LassmanAndrew B. Lassman, MD, MS, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Chicago, IL, Department of Public Health Sciences, University of Chicago, Chicago, IL; Fabio M. Iwamoto, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY,Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Vinai Gondi, MD, Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL; Erik P. Sulman, MD, PhD, Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, Duke Cancer Institute, Durham, NC; Jedd D. Wolchok, MD, PhD, Meyer Cancer Center and Department of Medicine, Weill Cornell Medicine, New York, NY, NewYork-Presbyterian, New York, NY; and Minesh P. Mehta, MD, Department of Oncological Sciences, Florida International University, and Miami Cancer Institute, Baptist Health South Florida, Miami, FL.ORCID 0000-0001-7386-9928
Mei-Yin C PolleyAndrew B. Lassman, MD, MS, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Chicago, IL, Department of Public Health Sciences, University of Chicago, Chicago, IL; Fabio M. Iwamoto, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY,Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Vinai Gondi, MD, Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL; Erik P. Sulman, MD, PhD, Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, Duke Cancer Institute, Durham, NC; Jedd D. Wolchok, MD, PhD, Meyer Cancer Center and Department of Medicine, Weill Cornell Medicine, New York, NY, NewYork-Presbyterian, New York, NY; and Minesh P. Mehta, MD, Department of Oncological Sciences, Florida International University, and Miami Cancer Institute, Baptist Health South Florida, Miami, FL.ORCID 0000-0003-0106-0323
Fabio M IwamotoAndrew B. Lassman, MD, MS, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Chicago, IL, Department of Public Health Sciences, University of Chicago, Chicago, IL; Fabio M. Iwamoto, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY,Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Vinai Gondi, MD, Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL; Erik P. Sulman, MD, PhD, Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, Duke Cancer Institute, Durham, NC; Jedd D. Wolchok, MD, PhD, Meyer Cancer Center and Department of Medicine, Weill Cornell Medicine, New York, NY, NewYork-Presbyterian, New York, NY; and Minesh P. Mehta, MD, Department of Oncological Sciences, Florida International University, and Miami Cancer Institute, Baptist Health South Florida, Miami, FL.
Vinai GondiAndrew B. Lassman, MD, MS, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Chicago, IL, Department of Public Health Sciences, University of Chicago, Chicago, IL; Fabio M. Iwamoto, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY,Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Vinai Gondi, MD, Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL; Erik P. Sulman, MD, PhD, Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, Duke Cancer Institute, Durham, NC; Jedd D. Wolchok, MD, PhD, Meyer Cancer Center and Department of Medicine, Weill Cornell Medicine, New York, NY, NewYork-Presbyterian, New York, NY; and Minesh P. Mehta, MD, Department of Oncological Sciences, Florida International University, and Miami Cancer Institute, Baptist Health South Florida, Miami, FL.ORCID 0009-0002-3963-0539
Erik P SulmanAndrew B. Lassman, MD, MS, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Chicago, IL, Department of Public Health Sciences, University of Chicago, Chicago, IL; Fabio M. Iwamoto, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY,Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Vinai Gondi, MD, Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL; Erik P. Sulman, MD, PhD, Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, Duke Cancer Institute, Durham, NC; Jedd D. Wolchok, MD, PhD, Meyer Cancer Center and Department of Medicine, Weill Cornell Medicine, New York, NY, NewYork-Presbyterian, New York, NY; and Minesh P. Mehta, MD, Department of Oncological Sciences, Florida International University, and Miami Cancer Institute, Baptist Health South Florida, Miami, FL.ORCID 0000-0003-4933-9120
Jedd D WolchokAndrew B. Lassman, MD, MS, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Chicago, IL, Department of Public Health Sciences, University of Chicago, Chicago, IL; Fabio M. Iwamoto, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY,Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Vinai Gondi, MD, Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL; Erik P. Sulman, MD, PhD, Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, Duke Cancer Institute, Durham, NC; Jedd D. Wolchok, MD, PhD, Meyer Cancer Center and Department of Medicine, Weill Cornell Medicine, New York, NY, NewYork-Presbyterian, New York, NY; and Minesh P. Mehta, MD, Department of Oncological Sciences, Florida International University, and Miami Cancer Institute, Baptist Health South Florida, Miami, FL.ORCID 0000-0001-6718-2222
Minesh P MehtaAndrew B. Lassman, MD, MS, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Mei-Yin C. Polley, PhD, NRG Oncology Statistics and Data Management Center, Chicago, IL, Department of Public Health Sciences, University of Chicago, Chicago, IL; Fabio M. Iwamoto, MD, Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY,Herbert Irving Comprehensive Cancer Center, New York, NY, NewYork-Presbyterian, New York, NY; Vinai Gondi, MD, Department of Radiation Oncology, Northwestern Medicine Cancer Center Warrenville and Proton Center, Warrenville, IL; Erik P. Sulman, MD, PhD, Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, Duke Cancer Institute, Durham, NC; Jedd D. Wolchok, MD, PhD, Meyer Cancer Center and Department of Medicine, Weill Cornell Medicine, New York, NY, NewYork-Presbyterian, New York, NY; and Minesh P. Mehta, MD, Department of Oncological Sciences, Florida International University, and Miami Cancer Institute, Baptist Health South Florida, Miami, FL.ORCID 0000-0002-4812-5713
Funding
NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8MStatistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Elaina Harper · 2014 to 2026
$146.4MTumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3MClinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0MNRG Oncology Biospecimen BankU24CA196067 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Tanner J. Freeman, Nilsa Del Carmen Ramirez Milan · 2015 to 2026
$42.6MColumbia University NCI Community Oncology Research ProgramUG1CA189960 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jennifer E. Amengual, Lisa A. Kachnic · 2014 to 2026
$12.7MClinical Trials Specialist in NCI Clinical Trials ResearchR50CA288588 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Andrew B Lassman · 2025 to 2026
$388kNCATS NIH HHS UL1 TR001873NCI NIH HHS P30 CA013696NCI NIH HHS R50 CA288588NCI NIH HHS U10 CA180822NCI NIH HHS U10 CA180868NCI NIH HHS U24 CA196067NCI NIH HHS UG1 CA189960
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.